FDA will approve breast cancer drug - herceptin ?
FDA will approve breast cancer drug - herceptin ?
It’s been a while since herceptin has been tested vigorously.We believe it will bring some hopes to breast cancer patients..
below is the story from cnn..
NEW YORK (CNNMoney.com) — The Food and Drug Administration is expected to approve a breast cancer treatment from GlaxoSmithKline on Tuesday, analysts say.
The FDA is reviewing Glaxo’s (up $0.23 to $55.82, Charts) tykerb, a breast cancer pill for patients who were previously and unsuccessfully treated with Genentech’s (down $0.13 to $81.45, Charts) Herceptin, a $1.2 billion drug. There is little doubt that the agency will approve tykerb, since the drug was awarded fast-track priority status.
…
